Synthon Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SYNTHON PHARMS INC, and what generic and branded alternatives to SYNTHON PHARMS INC drugs are available?
SYNTHON PHARMS INC has three approved drugs.
Summary for Synthon Pharms Inc
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 3 |
Drugs and US Patents for Synthon Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synthon Pharms Inc | GLATIRAMER ACETATE | glatiramer acetate | INJECTABLE;SUBCUTANEOUS | 206873-001 | Sep 25, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Synthon Pharms Inc | PALBOCICLIB | palbociclib | TABLET;ORAL | 215570-001 | Jun 5, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Synthon Pharms Inc | PALBOCICLIB | palbociclib | TABLET;ORAL | 215570-002 | Jun 5, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Synthon Pharms Inc | GLATIRAMER ACETATE | glatiramer acetate | INJECTABLE;SUBCUTANEOUS | 203857-001 | Sep 25, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Synthon Pharms Inc | PALBOCICLIB | palbociclib | TABLET;ORAL | 215570-003 | Jun 5, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
